Researchers from the University of Aberdeen have shown that a drug being trialled for the treatment of breast cancer and diabetes is capable of ‘melting away’ the fat build up inside arteries that can cause heart attacks and strokes.
Here, Mario Scigliano, serialisation & automation manager, and Christian Ahlmark, associate director, sales & key account management, CordenPharma, discuss how a CDMO can help give companies a fighting chance to be globally serialisation compliant.
In this article, Katharina Paulsen, Ines Ruff, Dirk Leister, Jennifer Ramirez and Robert Heintz from Thermo Fisher Scientific, describe a co-extrusion technique and how Raman imaging microscopy was used to analyse the extruded material.
During this year’s CPhI Worldwide congress in Frankfurt, the India Brand Equity Foundation and the Pharmaceuticals Export Promotion Council provided an update on India’s generics market, confirming it accounts for 98% of the marketplace
In this roundtable, four industry leaders from Symbiosis Pharmaceutical Services, Recipharm, Sterling Pharma Solutions and Idifarma, reveal their thoughts on what the ‘mega trends’ are in the current pharma landscape.
In this case study, IMA Active and Zambon discuss how the Cyclops tumble bin blender assisted the formulation and blending from laboratory scale while following recommended guidelines.
Robert Gaertner, director of strategy for quality at Veeva Systems in Europe, reveals the top five reasons why quality management should be moved to the cloud.
In the second part of the CPhI Worldwide Annual Report it has been revealed that the trend towards the increased use of modern manufacturing processes and quality systems is occurring very slowly and the current drugs pipeline is discouraging.
It’s that time of year again, CPhI Worldwide is back and this time is taking place in the financial centre of Europe — Frankfurt-am-Main, Germany. In this preview, the event organisers reveal what we can expect from this global and exciting show
Global health science marketing and communications firm, SCORR Marketing, has released a new study, in partnership with Applied Clinical Trials, evaluating the extent to which collaborations occur in the life sciences what influences them
